Tilray Brands falls on missing Q3 revenue expectations

Shares of cannabis firm Tilray Brands TLRY.O down 3.2% at $0.58

Co reports Q3 rev. of $185.8 mln, missing analysts' estimate $210 mln, as per data compiled by LSEG

Says adj. EPS remained at $0.00 in both Q3 & comparative period

Adds, Tilray’s wellness business, Manitoba Harvest, is currently exempt from new tariffs

Co conducted an analysis of potential implications on its business concluding that these tariffs should not impact sales

TLRY revises fiscal year 2025 net revenue outlook to a range of $850 mln to $900 mln, down from previous estimate of $950 million to $1 billion

As of last close, stock down ~56.4% YTD